Financials
Financial year 2025
DEKAMED from Court-Saint-Etienne, company number BE0669787077, closed financial year 2025 with a result of € 13,607 after tax. For that financial year DEKAMED recorded a gross margin of € 46,052 and equity of € 85,667. Compared with financial year 2024, the result moved from € 30,973 to € 13,607. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.
€ 85,667
▼ 21% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 13,607
▼ 56% vs 2024
Profit after tax over the fiscal year.
€ 49,352
▼ 58% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 36,864 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 44,086
▼ 5% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 26,763
▼ 23% vs 2024
€ 8,363 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 54
▼ 99% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 259
▼ 89% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -10,682 | € 35,058 | € 68,576 | € 46,052 | ▼ 33% |
| Profit after taxes | € -25,158 | € 19,058 | € 30,973 | € 13,607 | ▼ 56% |
| Equity | € 134,752 | € 117,810 | € 108,924 | € 85,667 | ▼ 21% |
| Total debts | € 26,418 | € 45,976 | € 81,587 | € 27,867 | ▼ 66% |
| Cash | € 106,345 | € 119,529 | € 118,069 | € 49,352 | ▼ 58% |
| Retained profit | € 128,552 | € 111,610 | € 102,724 | € 79,467 | ▼ 23% |
| Dividend | € 6,300 | € 36,000 | € 39,859 | € 36,864 | ▼ 8% |
| Bank debt | € 18,525 | € 4,675 | € 34,836 | € 26,763 | ▼ 23% |
| Balance sheet total | € 161,170 | € 163,786 | € 190,511 | € 113,533 | ▼ 40% |
Key figures of DEKAMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DEKAMED?
What happened at DEKAMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 13,607 (▼ 56% vs 2024). Source: NBB ↗
- New establishment in Court-Saint-Etienne. KBO
- Mathieu KRUG became a director. NBB
- Chloé MEYLEMANS became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 25,158 loss in 2022 to € 13,607 profit in 2025.
Paid € 19,751 in corporate taxes since 2022.
Best year ever: 2024, with € 30,973 profit.
Paid out € 119,023 in dividends to the owners in total.
Management
Behind DEKAMED are Mathieu KRUG and Chloé MEYLEMANS. The same people are also behind CMMED.
Establishments
Establishment units
Physical locations of this company
Rue d'Heuval 20
1490 Court-Saint-Etienne
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0669.787.077
- VAT number
- BE 0669.787.077
- Registered office
- Rue d'Heuval 20, 1490 Court-Saint-Etienne
- Names & denominations
- DEKAMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 January 2017
- Peppol
- Active · Active since 11 Jan 2026
- Activities · NACE
Activiteiten van huisartspraktijken